M. Navarro

429 total citations
16 papers, 327 citations indexed

About

M. Navarro is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, M. Navarro has authored 16 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in M. Navarro's work include Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). M. Navarro is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). M. Navarro collaborates with scholars based in Spain, Mexico and France. M. Navarro's co-authors include Vı́ctor Moreno, Elisabet Guinó, Federico Canzian, Caridad Pontes, David G. Cox, E. Marcuello, Enrique Aranda, Alfredo Carrato, Manuel Benavides and Albert Abad and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

M. Navarro

14 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Navarro Spain 8 190 88 86 66 61 16 327
Dong Ki Nam South Korea 6 79 0.4× 121 1.4× 162 1.9× 93 1.4× 98 1.6× 10 384
N.M. Forones Brazil 8 107 0.6× 61 0.7× 17 0.2× 88 1.3× 37 0.6× 18 278
Shi Yang China 13 78 0.4× 110 1.3× 32 0.4× 42 0.6× 43 0.7× 27 329
R Valanzano Italy 8 151 0.8× 50 0.6× 87 1.0× 59 0.9× 64 1.0× 12 331
Itsuro Terada Japan 7 143 0.8× 124 1.4× 19 0.2× 79 1.2× 8 0.1× 23 338
Hong-Chuan Zhao China 9 60 0.3× 118 1.3× 44 0.5× 71 1.1× 6 0.1× 14 301
Olivier Béatrix France 7 117 0.6× 87 1.0× 18 0.2× 115 1.7× 50 0.8× 14 331
Gurpreet Singh‐Ranger United Kingdom 10 72 0.4× 50 0.6× 131 1.5× 82 1.2× 103 1.7× 24 332
Jingzhe Sui China 13 76 0.4× 199 2.3× 17 0.2× 82 1.2× 40 0.7× 21 380
Yusuke Hara Japan 11 78 0.4× 193 2.2× 20 0.2× 19 0.3× 29 0.5× 30 383

Countries citing papers authored by M. Navarro

Since Specialization
Citations

This map shows the geographic impact of M. Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Navarro more than expected).

Fields of papers citing papers by M. Navarro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Navarro. The network helps show where M. Navarro may publish in the future.

Co-authorship network of co-authors of M. Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of M. Navarro. A scholar is included among the top collaborators of M. Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Navarro. M. Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Navarro, M., Miguel Ángel Ramos-López, Aldo Amaro-Reyes, et al.. (2024). Biocontrol Activity of Bacillus altitudinis CH05 and Bacillus tropicus CH13 Isolated from Capsicum annuum L. Seeds against Fungal Strains. Microorganisms. 12(10). 1943–1943. 4 indexed citations
2.
Navarro, M., Juan Ramiro Pacheco-Aguilar, Miguel Ángel Ramos-López, et al.. (2024). Role of Volatile Organic Compounds Produced by Kosakonia cowanii Cp1 during Competitive Colonization Interaction against Pectobacterium aroidearum SM2. Microorganisms. 12(5). 930–930. 3 indexed citations
3.
Navarro, M., C. Alvarado, Miguel Ángel Ramos-López, et al.. (2024). A Study of Resistome in Mexican Chili Powder as a Public Health Risk Factor. Antibiotics. 13(2). 182–182.
4.
Santos, Cristina, Adriana López‐Doriga, M. Navarro, et al.. (2012). Clinicopathological risk factors of Stage II colon cancer: results of a prospective study. Colorectal Disease. 15(4). 414–422. 33 indexed citations
5.
Martinez‐Balibrea, Eva, Albert Abad, Anna Martínez‐Cardús, et al.. (2010). UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy. British Journal of Cancer. 103(4). 581–589. 72 indexed citations
7.
8.
Mollevı́, David G., Teresa Serrano, M. Morell, et al.. (2007). Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. Carcinogenesis. 28(6). 1241–1246. 29 indexed citations
9.
Majem, Margarita, Maica Galán, Montserrat Muñoz-Mateu, et al.. (2007). The oncology acute toxicity unit (OATU): an outpatient facility for improving the management of chemotherapy toxicity. Clinical & Translational Oncology. 9(12). 784–788. 20 indexed citations
10.
Marcuello, E., Javier Sastre, M. Navarro, et al.. (2004). Biweekly irinotecan (CPT-11) plus 5-FU as first-line chemotherapy for elderly patients with metastatic colorectal cancer (MCRC). Final results of the Spanish Digestive Group (TTD) study. Journal of Clinical Oncology. 22(14_suppl). 3597–3597. 2 indexed citations
11.
Cox, David G., Caridad Pontes, Elisabet Guinó, et al.. (2004). Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. British Journal of Cancer. 91(2). 339–343. 118 indexed citations
12.
Marcuello, E., Javier Sastre, M. Navarro, et al.. (2004). Biweekly irinotecan (CPT-11) plus 5-FU as first-line chemotherapy for elderly patients with metastatic colorectal cancer (MCRC). Final results of the Spanish Digestive Group (TTD) study. Journal of Clinical Oncology. 22(14_suppl). 3597–3597. 1 indexed citations
13.
Villanueva, Alberto, E. Dotor, Míriam Cuatrecasas, et al.. (2004). Comprehensive thymidylate synthase genotyping in adjuvant therapy of CRC. Journal of Clinical Oncology. 22(14_suppl). 3588–3588. 1 indexed citations
14.
Moreno, Vı́ctor, Elisabet Guinó, F. Xavier Bosch, et al.. (2002). Diet and K-ras mutations in colorectal cancer.. PubMed. 156. 501–2. 1 indexed citations
15.
Majem, Margarita, M. Navarro, Ander Urruticoechea, et al.. (2001). Early recurrence and genetic alterations in colorectal cancer. European Journal of Cancer. 37. S257–S257.
16.
Díaz‐Rubio, Eduardo, Javier Sastre, Albert Abad, et al.. (1999). UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.. PubMed. 13(7 Suppl 3). 35–40. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026